IGF-II in the pathogenesis of rhabdomyosarcoma: a prototype of IGFs involvement in human tumorigenesis.
Minniti
C P
CP
Pediatric Department, Georgetown University Medical Center, Washington, DC 20007.
Helman
L J
LJ
D000328:Adult; D002352:Carrier Proteins / Q000096:biosynthesis; D002455:Cell Division / Q000187:drug effects; D002465:Cell Movement; D004622:Embryo, Mammalian; D005091:Exons; D015870:Gene Expression; D006801:Humans; D018969:Insulin-Like Growth Factor Binding Proteins; D007335:Insulin-Like Growth Factor II / Q000096:biosynthesis / Q000494:pharmacology / Q000502:physiology*; D017526:Receptor, IGF Type 1 / Q000096:biosynthesis; D017527:Receptor, IGF Type 2 / Q000096:biosynthesis; D012208:Rhabdomyosarcoma / Q000473:pathology / Q000503:physiopathology*; D013498:Suramin / Q000494:pharmacology; D014407:Tumor Cells, Cultured
D002352:Carrier Proteins; D018969:Insulin-Like Growth Factor Binding Proteins; D017527:Receptor, IGF Type 2; D013498:Suramin; D007335:Insulin-Like Growth Factor II; D017526:Receptor, IGF Type 1